{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:22:10Z","timestamp":1787829730868,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangzhou Huadu District People's Hospital Institutional Research Fund Project","award":["2021-A01"],"award-info":[{"award-number":["2021-A01"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      In regions with a high prevalence of thalassemia, conventional diagnostic methods may fail to detect atypical or complex genetic variants. Whole-exome sequencing (WES) provides a comprehensive strategy to identify such variants, allowing more accurate genotype\u2013phenotype correlation. Nevertheless, its optimal integration into clinical workflows and its incremental value over standard diagnostic approaches remain uncertain. This study aimed to evaluate the clinical utility of WES in a heterogeneous patient cohort and to propose a framework for its rational use in endemic settings. WES was performed on 21 patients with clinically suspected thalassemia from Huadu District, Guangzhou, stratified by severity. Variant analysis encompassed both coding and noncoding regions. On average, 5440.7\u2005\u00b1\u200594.3 insertions\/deletions and 49,719.3\u2005\u00b1\u2005492.5 single-nucleotide variants per individual were detected. Frameshift insertions\/deletions were predominantly localized to the\n                      <jats:italic toggle=\"yes\">HBB<\/jats:italic>\n                      gene. Noncoding single-nucleotide variants in 3\u2032 untranslated regions were associated with reduced mean corpuscular hemoglobin (HGB) concentration (301\u2005\u00b1\u200525\u2009g\/L in patients with vs 321\u2005\u00b1\u200518\u2009g\/L in those without 3\u2032 untranslated region variants,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.008). Compound heterozygosity involving classical \u03b2-thalassemia mutations (CD41\/42(-TTCT) \u03b2\n                      <jats:sup>0<\/jats:sup>\n                      and IVS-II-654(C&gt;T) \u03b2\n                      <jats:sup>+<\/jats:sup>\n                      ) accounted for 85.7% of severe cases. Three rare non-\u03b2-globin variants were identified:\n                      <jats:italic toggle=\"yes\">MYB<\/jats:italic>\n                      c.107G&gt;A (p.R36H) in 1 case, a variant of uncertain significance potentially linked to fetal HGB regulation;\n                      <jats:italic toggle=\"yes\">HBD<\/jats:italic>\n                      c.440A&gt;T (p.H147L) in another, which produced an artificially normalized HbA\n                      <jats:sub>2<\/jats:sub>\n                      value (3.1%), creating a risk of \u03b2-thalassemia misdiagnosis; and\n                      <jats:italic toggle=\"yes\">HBG1<\/jats:italic>\n                      c.364G&gt;T (p.E122*) in a third case, co-occurring with \u03b1-thalassemia and iron deficiency. HGB levels declined significantly with increasing clinical severity (mild: 99.7\u2005\u00b1\u20052.5\u2009g\/L; very severe: 31.0\u2005\u00b1\u200526.1\u2009g\/L,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). WES proved to be a powerful diagnostic tool, identifying causative or contributing genetic variants in all patients in this cohort, including those with complex or atypical presentations. Although it may not yet be feasible as a first-tier screening approach due to cost constraints, our findings strongly support the selective integration of WES into existing thalassemia diagnostic workflows in endemic regions. Such an approach enhances diagnostic precision, clarifies complex genotypes, and can guide more individualized management strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049002","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:06:17Z","timestamp":1780074377000},"page":"e49002","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Unmasking rare thalassemia variants through whole-exome sequencing in Huadu District, China: An observational study"],"prefix":"10.1097","volume":"105","author":[{"given":"Run","family":"Guowei","sequence":"first","affiliation":[{"name":"Department of Hematology, Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"},{"name":"Huadu Institute of Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Yan","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Xuan Wu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Jingxia","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Changlv","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Huadu Institute of Medicine, Guangzhou, China"},{"name":"Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Lihua","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"},{"name":"Huadu Institute of Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bizhen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"},{"name":"Huadu Institute of Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Jingnan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"},{"name":"Huadu Institute of Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Cuijin","sequence":"additional","affiliation":[{"name":"Third Clinical School of Medicine, Southern Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Yulan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"},{"name":"Huadu Institute of Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"HaoHao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"},{"name":"Huadu Institute of Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6824-1527","authenticated-orcid":false,"given":"Ji","family":"Linhua","sequence":"additional","affiliation":[{"name":"Department of Hematology, Huadu District People\u2019s Hospital of Guangzhou, Guangzhou, China"},{"name":"Huadu Institute of Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260827","doi-asserted-by":"crossref","first-page":"10760296221119807","DOI":"10.1177\/10760296221119807","article-title":"Molecular epidemiology and hematologic characterization of thalassemia in Guangdong Province, Southern China.","volume":"28","author":"Xian","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"R2-20260827","doi-asserted-by":"crossref","first-page":"e23596","DOI":"10.1002\/jcla.23596","article-title":"Molecular epidemiological and hematological profile of thalassemia in the Dongguan Region of Guangdong Province, Southern China.","volume":"35","author":"Peng","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"R3-20260827","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.3390\/ijms25147793","article-title":"An integrated transcriptomics and genomics approach detects an X\/autosome translocation in a female with Duchenne muscular dystrophy.","volume":"25","author":"Segarra-Casas","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R4-20260827","doi-asserted-by":"crossref","first-page":"2187155","DOI":"10.1080\/16078454.2023.2187155","article-title":"Whole exome sequencing and rare variant association study to identify genetic modifiers, KLF1 mutations, and a novel double mutation in Thai patients with hemoglobin E\/beta-thalassemia.","volume":"28","author":"Hantaweepant","year":"2023","journal-title":"Hematology"},{"key":"R5-20260827","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R6-20260827","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1002\/imt2.107","article-title":"Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp.","volume":"2","author":"Chen","year":"2023","journal-title":"Imeta"},{"key":"R7-20260827","first-page":"1039","article-title":"Associations between BCL11A and HBS1L-MYB polymorphisms and thalassemia risk.","volume":"19","author":"Bashir","year":"2024","journal-title":"J Taibah Univ Med Sci"},{"key":"R8-20260827","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/thalassrep14040011","article-title":"Disease-modifying effect of HBS1L-MYB in HbE\/\u03b2-thalassemia patients in Bangladeshi population.","volume":"14","author":"Ferdous","year":"2024","journal-title":"Thalassemia Reports"},{"key":"R9-20260827","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/biom11050755","article-title":"Epigenetic insights and potential modifiers as therapeutic targets in \u03b2-thalassemia.","volume":"11","author":"Zakaria","year":"2021","journal-title":"Biomolecules"},{"key":"R10-20260827","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/ejh.ejh_22_22","article-title":"The role of HBG2, BCL11A, and HBS1L-MYB in early diagnosis of transfusion-dependent thalassemia among Egyptian children.","volume":"48","author":"Shabaan","year":"2023","journal-title":"Egypt J Haematol"},{"key":"R11-20260827","first-page":"e52002","article-title":"Unraveling impact of hemoglobin F and A2 levels: correlation with disease severity and treatment response in transfusion-dependent beta-thalassemia.","volume":"16","author":"Nawaz","year":"2024","journal-title":"Cureus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:01:51Z","timestamp":1787828511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":11,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049002","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2025-08-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}